Naphthol AS-BI N-acetyl-b-D-glucosaminide

萘酚AS-BI N-乙酰基-β-D-氨基葡萄糖苷, 

Naphthol AS-BI N-acetyl-b-D-glucosaminide is an enzyme inhibitor that is used in the treatment of Gaucher's disease. The enzyme it inhibits is β-glucosidase, which breaks down glucocerebrosides in the lysosomes of cells. This drug prevents the breakdown of glucocerebrosides and increases their concentration in cells, which reduces the symptoms of Gaucher's disease. Naphthol AS-BI N-acetyl-b-D-glucosaminide has been shown to be effective against wild type and mutant forms of the enzyme. However, it does not work against patients who are homozygous for a mutation in exon 1 of the βglu gene that codes for βglu protein.

Naphthol AS-BI N-acetyl-beta-D-glucosaminide is a compound that has been widely studied in the field of biomedical research due to its numerous potential applications in medicine and related fields. In this paper, we will provide an overview of the physical and chemical properties, synthesis and characterization, analytical methods, biological properties, toxicity and safety in scientific experiments, applications in scientific experiments, current state of research, potential implications in various fields of research and industry, limitations, and future directions of Naphthol AS-BI N-acetyl-beta-D-glucosaminide.